Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells

  1. David Moreno Delgado
  2. Thor C Møller
  3. Jeanne Ster
  4. Jesús Giraldo
  5. Damien Maurel
  6. Xavier Rovira
  7. Pauline Scholler
  8. Jurrian M Zwier
  9. Julie Perroy
  10. Thierry Durroux
  11. Eric Trinquet
  12. Laurent Prezeau
  13. Philippe Rondard
  14. Jean-Philippe Pin  Is a corresponding author
  1. CNRS, INSERM, Univ Montpellier, France
  2. CNRS, INSERM, Université de Montpellier, France
  3. Universitat Autònoma de Barcelona, Spain
  4. Cisbio bioassays, France

Abstract

Metabotropic glutamate receptors (mGluRs) are mandatory dimers playing important roles in regulating CNS function. Although assumed to form exclusive homodimers, sixteen possible heterodimeric mGluRs have been proposed but their existence in native cells remains elusive. Here we set up two assays to specifically identify the pharmacological properties of rat mGlu heterodimers composed of mGlu2 and 4 subunits. We used either a heterodimer specific conformational LRET-based biosensor, or a system that guarantees the cell surface targeting of the heterodimer only. We identified mGlu2-4 specific pharmacological fingerprints that were also observed in a neuronal cell line and in lateral perforant path terminals naturally expressing mGlu2 and mGlu4. These results bring strong evidence for the existence of mGlu2-4 heterodimers in native cells. In addition to reporting a general approach to characterize heterodimeric mGluRs, our study opens new avenues to understanding the pathophysiological roles of mGlu heterodimers.

Article and author information

Author details

  1. David Moreno Delgado

    Institut de Genomique Fonctionnelle, CNRS, INSERM, Univ Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  2. Thor C Møller

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  3. Jeanne Ster

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  4. Jesús Giraldo

    Laboratory of Molecular Neuropharmacology and Bioinformatics, Universitat Autònoma de Barcelona, Bellaterra, Spain
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7082-4695
  5. Damien Maurel

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  6. Xavier Rovira

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9764-9927
  7. Pauline Scholler

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  8. Jurrian M Zwier

    Cisbio bioassays, Codolet, France
    Competing interests
    Jurrian M Zwier, Dr Zwier is working at Cisbio Bioassays, a company selling HTRF tools.
  9. Julie Perroy

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  10. Thierry Durroux

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  11. Eric Trinquet

    Cisbio bioassays, Codolet, France
    Competing interests
    Eric Trinquet, He is head of R&D at CisBio Bioassays.
  12. Laurent Prezeau

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  13. Philippe Rondard

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    No competing interests declared.
  14. Jean-Philippe Pin

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    For correspondence
    jppin@igf.cnrs.fr
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1423-345X

Funding

Fondation recherche médicale DEQ20130326522 (DEQ20130326522)

  • Jean-Philippe Pin

CisBio bioassays (Laboratoire Collaboratif)

  • Jean-Philippe Pin

ERA-NET Neuron (PCIN-2013-018-C03-02)

  • Jesús Giraldo

ERA-NET Neuron (SAF2014-58396-R)

  • Jesús Giraldo

Agence Nationale de la Recherche (ANR-09-BIOT-018)

  • Eric Trinquet
  • Philippe Rondard
  • Jean-Philippe Pin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Moreno Delgado et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,026
    views
  • 508
    downloads
  • 76
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David Moreno Delgado
  2. Thor C Møller
  3. Jeanne Ster
  4. Jesús Giraldo
  5. Damien Maurel
  6. Xavier Rovira
  7. Pauline Scholler
  8. Jurrian M Zwier
  9. Julie Perroy
  10. Thierry Durroux
  11. Eric Trinquet
  12. Laurent Prezeau
  13. Philippe Rondard
  14. Jean-Philippe Pin
(2017)
Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells
eLife 6:e25233.
https://doi.org/10.7554/eLife.25233

Share this article

https://doi.org/10.7554/eLife.25233

Further reading

    1. Cell Biology
    2. Genetics and Genomics
    Róża K Przanowska, Yuechuan Chen ... Anindya Dutta
    Research Article

    The six-subunit ORC is essential for the initiation of DNA replication in eukaryotes. Cancer cell lines in culture can survive and replicate DNA replication after genetic inactivation of individual ORC subunits, ORC1, ORC2, or ORC5. In primary cells, ORC1 was dispensable in the mouse liver for endo-reduplication, but this could be explained by the ORC1 homolog, CDC6, substituting for ORC1 to restore functional ORC. Here, we have created mice with a conditional deletion of ORC2, which does not have a homolog. Although mouse embryo fibroblasts require ORC2 for proliferation, mouse hepatocytes synthesize DNA in cell culture and endo-reduplicate in vivo without ORC2. Mouse livers endo-reduplicate after simultaneous deletion of ORC1 and ORC2 both during normal development and after partial hepatectomy. Since endo-reduplication initiates DNA synthesis like normal S phase replication these results unequivocally indicate that primary cells, like cancer cell lines, can load MCM2-7 and initiate replication without ORC.

    1. Cell Biology
    2. Developmental Biology
    Pavan K Nayak, Arul Subramanian, Thomas F Schilling
    Research Article Updated

    Mechanical forces play a critical role in tendon development and function, influencing cell behavior through mechanotransduction signaling pathways and subsequent extracellular matrix (ECM) remodeling. Here, we investigate the molecular mechanisms by which tenocytes in developing zebrafish embryos respond to muscle contraction forces during the onset of swimming and cranial muscle activity. Using genome-wide bulk RNA sequencing of FAC-sorted tenocytes we identify novel tenocyte markers and genes involved in tendon mechanotransduction. Embryonic tendons show dramatic changes in expression of matrix remodeling associated 5b (mxra5b), matrilin 1 (matn1), and the transcription factor kruppel-like factor 2a (klf2a), as muscles start to contract. Using embryos paralyzed either by loss of muscle contractility or neuromuscular stimulation we confirm that muscle contractile forces influence the spatial and temporal expression patterns of all three genes. Quantification of these gene expression changes across tenocytes at multiple tendon entheses and myotendinous junctions reveals that their responses depend on force intensity, duration, and tissue stiffness. These force-dependent feedback mechanisms in tendons, particularly in the ECM, have important implications for improved treatments of tendon injuries and atrophy.